Valganciclovir For Solution
Product Images NDC 59651-444

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Valganciclovir (NDC 59651-444). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Valganciclovir Fig1)

Illustrative formulas for calculating body surface area (Mosteller BSA) and creatinine clearance (Schwartz method). The diagram shows the Mosteller BSA formula involving height in centimeters and weight in kilograms, and the Schwartz creatinine clearance formula involving height, serum creatinine, and a constant k.*

FDA Label Image

Figure 9 (Valganciclovir Fig10)

An instructional line drawing illustrating the administration of oral medication to a child using a syringe. The image depicts a hand holding a syringe close to the child's mouth for oral dosing.*

FDA Label Image

Figure 10 (Valganciclovir Fig11)

An instructional illustration showing how to open a bottle by twisting the cap counterclockwise, indicated by a curved arrow pointing left. The illustration focuses on the bottle neck and cap.*

FDA Label Image

Figure 11 (Valganciclovir Fig12)

An instructional illustration showing liquid drops from a faucet falling into a syringe, demonstrating measurement or dilution of a solution for oral administration.*

FDA Label Image

Figure 12 (Valganciclovir Fig13)

A line drawing illustration of an oral syringe, marked with measurement gradations typical for dosing liquid medication. The syringe is depicted without a needle, indicating use for oral administration.*

FDA Label Image

Package Label Principal Display Panel Container Label (Valganciclovir Fig14)

Label for Valganciclovir for Oral Solution 50 mg/mL by Aurobindo Pharma Limited. It shows dosage instructions, net contents of 100 mL after constitution, preparation directions for pharmacists, storage conditions, distributor information, and includes an NDC number 59651-444-01. The label is for a powder for oral solution.*

FDA Label Image

Package Label Principal Display Panel Carton Label (Valganciclovir Fig15)

Carton packaging label for Valganciclovir for Oral Solution 50 mg/mL by Aurobindo Pharma Limited. The label indicates each mL of constituted oral solution contains 50 mg valganciclovir free base. The package size is 100 mL (3.4 fl oz) and includes instructions for pharmacists on preparation, storage, and dispensing, along with a barcode and distributor information.*

FDA Label Image

Figure 1 (Valganciclovir Fig2)

Illustration showing components of an oral dispenser system used with valganciclovir oral solution. It includes a labeled diagram of a bottle with a child resistant cap and bottle adapter, alongside a detachable oral dispenser with a plunger, barrel marked with volume gradations, and tip.*

FDA Label Image

Figure 2 (Valganciclovir Fig3)

An instructional illustration showing a hand holding a bottle with the text 'Shake well,' indicating the proper technique to shake the bottle before use.*

FDA Label Image

Figure 3 (Valganciclovir Fig4)

An instructional line drawing illustrating how to open a vial by twisting the cap in the direction indicated by arrows. No text or product labeling is visible.*

FDA Label Image

Figure 4 (Valganciclovir Fig5)

An instructional illustration showing a syringe with a dosage indicator in milliliters (mL) marked on the barrel. The diagram highlights the dosage indicator feature for measuring liquid medication volume up to 10 mL.*

FDA Label Image

Figure 5 (Valganciclovir Fig6)

An instructional illustration showing a hand pressing down on the top of a syringe, presumably to eject or administer the liquid inside. The syringe is marked with graduated measurement lines and is held between the thumb and fingers.*

FDA Label Image

Figure 6 (Valganciclovir Fig7)

An instructional illustration showing a hand holding a syringe aligned with a bottle adapter opening, with an arrow indicating downward insertion of the syringe into the bottle. This diagram likely demonstrates how to connect the syringe to the bottle for drawing or mixing liquid medication.*

FDA Label Image

Figure 7 (Valganciclovir Fig8)

An instructional illustration showing the process of drawing liquid medication from a bottle into an oral syringe. The left side depicts hands holding the bottle upside down with the syringe attached, while the right side shows a close-up of the syringe with measurement markings being filled with medication.*

FDA Label Image

Figure 8 (Valganciclovir Fig9)

An instructional illustration showing a hand pulling up a syringe plunger to draw oral solution from a bottle. The image visually guides the proper method to measure and withdraw liquid medication, relevant for Valganciclovir oral solution preparation.*

FDA Label Image

Chemical Structure (Valganciclovir Str)

Chemical structure diagram of Valganciclovir hydrochloride, illustrating the molecular arrangement of atoms and bonds in the compound used as the active ingredient in Valganciclovir oral solution.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.